BioVenture Builder
About
The BioVenture Builder is a bold new initiative designed to empower preclinical ventures in the Drug Discovery & Development space. In collaboration with 3D-PharmXchange and Odgers, BOM offers a tailor-made, hands-on support programme focused on validation and integrated strategy development, covering product, team, IP, and regulatory pathways.
This isn’t just early-stage support. We continue to back you as you grow beyond the initial phase. Our mission? To accelerate biotech ventures toward becoming investor-ready and securing the funding they need to thrive.
Eligibility Criteria & Application Process
The BioVenture Builder welcomes ventures working on:
Preclinical asset development, or
R&D-accelerating technology development
To qualify, your venture should meet the following criteria:
Clinical relevance & market potential
Your innovation addresses a clear unmet medical or customer need.
Innovative technology with IP potential
Your solution is built on a novel technology with strong intellectual property prospects.
Preliminary market insights
You’ve gained initial insights into the competitive landscape and pipeline dynamics.
Founder commitment & vision
You bring a clear vision and are fully committed to building a successful venture.
Chamber of Commerce registration
Your company is registered and less than 7 years old.
How to apply
Click the registration button to submit your application. Once received, we’ll review your eligibility. If you qualify, we’ll schedule an introductory call with our industry partners to explore your business case and prepare you for your BioVenture Builder journey.
Contact
Please do not hesitate to contact us if you have any questions:
Britta Driessen
Venture Developer at BOM
M: 06-41257853
BioVenture Builder
Registration website for BioVenture BuilderBioVenture Builderevents@bom.nl
BioVenture Builderevents@bom.nlhttps://www.bomevents.nl/bioventurebuilder
2026-12-31
2026-12-31
OfflineEventAttendanceMode
EventScheduled
BioVenture BuilderBioVenture Builder0.00EUROnlineOnly2019-01-01T00:00:00Z
To be announcedTo be announced